Alliance for Pandemic Preparedness
June 18, 2020
GLUCOCOVID A Controlled Trial of Methylprednisolone in Adults Hospitalized with COVID-19 Pneumonia
Category: Article Summary
Topic: Testing and Treatment
- [pre-print, not peer reviewed] In a partially randomized open-label trial among patients hospitalized with COVID-19 pneumonia (n=85), methylprednisolone was associated with a reduced risk of death, ICU admission, or non-invasive ventilation (RR =0.55, 95% CI: 0.33-0.91).
Corral et al. (June 18, 2020). GLUCOCOVID A Controlled Trial of Methylprednisolone in Adults Hospitalized with COVID-19 Pneumonia. Pre-print downloaded June 18 from https://doi.org/10.1101/2020.06.17.20133579